[1]
V. Venugopal, J. MS, and T. Vidya, “Rosuvastatin Monotherapy Versus Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity, Vascular Inflammation, and Lipid Profile In Patients With Type 2 Diabetes Mellitus: A Randomised Controlled Trial”, Adolescência e Saúde, pp. 636–648, Sep. 2026.